79 related articles for article (PubMed ID: 8926686)
1. Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma.
Du J; Yuan X
Eur J Pediatr; 2024 Jan; 183(1):185-202. PubMed ID: 37855927
[TBL] [Abstract][Full Text] [Related]
2. Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center.
Jang JY; Park JH; Kim YJ; Im HJ; Koh KN; Kim H; Kang SH; Kim HU; Ahn SD
Turk J Pediatr; 2024; 66(1):99-109. PubMed ID: 38523384
[TBL] [Abstract][Full Text] [Related]
3. Role of image-defined risk factors in predicting surgical complications of localized neuroblastoma.
Liu T; Lv Z; Xu W; Liu J; Sheng Q
Pediatr Surg Int; 2020 Oct; 36(10):1167-1172. PubMed ID: 32851471
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological and some clinical characteristics of neuroblastoma in Mexican children (1996-2005).
Juárez-Ocaña S; Palma-Padilla V; González-Miranda G; Siordia-Reyes AG; López-Aguilar E; Aguilar-Martínez M; Mejía-Aranguré JM; Carreón-Cruz R; Rendón-Macías ME; Fajardo-Gutiérrez A
BMC Cancer; 2009 Aug; 9():266. PubMed ID: 19650918
[TBL] [Abstract][Full Text] [Related]
5. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations.
Saldana-Guerrero IM; Montano-Gutierrez LF; Boswell K; Hafemeister C; Poon E; Shaw LE; Stavish D; Lea RA; Wernig-Zorc S; Bozsaky E; Fetahu IS; Zoescher P; Pötschger U; Bernkopf M; Wenninger-Weinzierl A; Sturtzel C; Souilhol C; Tarelli S; Shoeb MR; Bozatzi P; Rados M; Guarini M; Buri MC; Weninger W; Putz EM; Huang M; Ladenstein R; Andrews PW; Barbaric I; Cresswell GD; Bryant HE; Distel M; Chesler L; Taschner-Mandl S; Farlik M; Tsakiridis A; Halbritter F
Nat Commun; 2024 May; 15(1):3745. PubMed ID: 38702304
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Outcome and Role of Biology within Risk-Adapted Treatment Strategies: The Austrian Neuroblastoma Trial A-NB94.
Fiedler S; Ambros IM; Glogova E; Benesch M; Urban C; Mayer M; Ebetsberger-Dachs G; Bardi E; Jones N; Gamper A; Meister B; Crazzolara R; Amann G; Dieckmann K; Horcher E; Kerbl R; Brunner-Herglotz B; Ziegler A; Ambros PF; Ladenstein R
Cancers (Basel); 2021 Feb; 13(3):. PubMed ID: 33540616
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma.
Yalçin B; Kremer LC; van Dalen EC
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD006301. PubMed ID: 26436598
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastoma in the very young child: biological considerations.
Kemshead JT; Patel K; Phimister B
Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
[TBL] [Abstract][Full Text] [Related]
9. [Past and future role of surgery in neuroblastoma].
Kaneko M
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):418-21. PubMed ID: 16045184
[TBL] [Abstract][Full Text] [Related]
10. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Ladenstein R; Ambros IM; Pötschger U; Amann G; Urban C; Fink FM; Schmitt K; Jones R; Slociak M; Schilling F; Ritter J; Berthold F; Gadner H; Ambros PF
Med Pediatr Oncol; 2001 Jan; 36(1):83-92. PubMed ID: 11464912
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in metastatic neuroblastoma in patients over 1 year of age treated with high-dose chemotherapy and stem cell transplantation: a multivariate analysis in 218 patients treated in a single institution.
Hartmann O; Valteau-Couanet D; Vassal G; Lapierre V; Brugières L; Delgado R; Couanet D; Lumbroso J; Benhamou E
Bone Marrow Transplant; 1999 Apr; 23(8):789-95. PubMed ID: 10231141
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.
Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R
N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999
[TBL] [Abstract][Full Text] [Related]
14. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
[TBL] [Abstract][Full Text] [Related]
15. [Neuroblastoma in children under than 1 year of age].
Castel Sánchez V; Melero Moreno C; García-Miguel García-Rosados P; Navajas Gutiérrez A; Ruiz Jiménez JI; Navarro Fos S; Garín Valle JC; Galbe Sada M
An Esp Pediatr; 1997 Dec; 47(6):584-90. PubMed ID: 9575117
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]